Asia-Pacific DTC Laboratory Testing Market to be Worth $1.58 Billion by 2030

Asia-Pacific DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Disease Risk [Cancer, Cardiac, Neurological], Carrier Status}, Diabetes, COVID, Routine, Thyroid), and Sample Type (Blood, Saliva, Urine) - Forecast to 2030

Meticulous Research^®—a leading market research company, published a research report titled, 'Asia-Pacific DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Disease Risk [Cancer, Cardiac, Neurological], Carrier Status}, Diabetes, COVID, Routine, Thyroid), and Sample Type (Blood, Saliva, Urine) - Forecast to 2030.’

According to this latest publication from Meticulous Research^®, the Asia-Pacific dtc laboratory testing market is projected to reach $1.58 billion by 2030, at a CAGR of 12.8% from 2023 to 2030. The growth of the Asia-Pacific dtc laboratory testing market is driven by several factors, including the rising incidence of chronic diseases and sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability & accessibility, increasing prevalence of chronic and infectious diseases, increasing cost of healthcare, and the rising elderly population. Factors such as the growing adoption of telehealth, expansion in emerging economies, and the increasing penetration of pharmacogenomic testing in DTC laboratory testing are a few of the opportunities that would help grow the market in the future.

Factors such as genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counseling could be considered challenges for the Asia-Pacific dtc laboratory testing market. However, the sample integrity and interference issues, regulatory concerns, lack of reimbursement, and limited test portfolio compared to conventional laboratory testing restrain the growth of the market.

Key Players

The key players profiled in the Asia-Pacific dtc laboratory testing market report are Metropolis Healthcare Limited (India), SRL Limited (India), Hirotsu Bio Science (Japan), Mapmygenome India Limited (India), Genesis Healthcare Co. (Japan), Augmentum Diagnostics (India), Apollo Health and Lifestyle Limited (India), WeGene (China), GeseDNATechnology LLP (China), Laboratory Corporation of America Holdings (U.S.), LetsGetChecked, Inc. (U.S.), and 23andMe Holding Co. (U.S.)

The Asia-Pacific dtc laboratory testing market is segmented by Application (Genetic Testing [Ancestry/Genealogy, Disease/Risk Assessment {Cancer, Cardiovascular Diseases, Neurological Diseases, Other Diseases}, Carrier Status, Other Genetic Tests], Diabetes Testing, Routine Clinical Testing, Thyroid Function Testing, Sexually Transmitted Disease Testing, Other Applications), Sample Type (Blood, Saliva, Urine, Other Samples) and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Among applications, in 2023, the genetic testing segment is expected to account for the largest share of the market. The large share of the segment is attributed to the rising appeal of DTC genetic testing to explore information regarding family health history and disease risk assessment testing, the launch of new DTC genetic tests for new applications, and increasing curiosity among people in developed countries regarding their ancestry and lineage.

Among sample types, the blood segment is expected to account for the largest share of the market. The large share of the segment is attributed to the large variety of available tests using blood samples, such as the high reliability of results, increasing prevalence of chronic diseases, increasing consumer awareness regarding the monitoring of chronic diseases, and the convenience of at-home blood collection services.

Geographic Review

This research report analyzes major Asia-Pacific geographies: China, Japan, India, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, and the Rest of Asia-Pacific. In 2023, China is expected to account for the largest share of the Asia-Pacific dtc laboratory testing market. China’s major market share is attributed to the large consumer population, increasing disposable income, and growing awareness regarding personal health monitoring.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5673

Key questions answered in the report:

Which are the high-growth market segments in terms of Asia Pacific dtc laboratory testing by application, sample, and geography?
What was the historical market for dtc laboratory testing across Asia-Pacific?
What are the market forecasts and estimates for the period 2023–2030?
What are the major drivers, restraints, opportunities, and challenges in the Asia-Pacific dtc laboratory testing market?
Who are the major players in the Asia-Pacific dtc laboratory testing market?
What is the competitive landscape, and who are the market leaders in the Asia-Pacific dtc laboratory testing market?
What are the recent developments in the Asia-Pacific dtc laboratory testing market?
What are the different strategies adopted by the major players in the Asia-Pacific dtc laboratory testing market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research